Author
Listed:
- Christopher M. Evans
(University of Colorado School of Medicine)
- Dorota S. Raclawska
(University of Colorado School of Medicine)
- Fani Ttofali
(University of Colorado School of Medicine)
- Deborah R. Liptzin
(University of Colorado School of Medicine)
- Ashley A. Fletcher
(University of Colorado School of Medicine)
- Daniel N. Harper
(University of Colorado School of Medicine)
- Maggie A. McGing
(University of Colorado School of Medicine)
- Melissa M. McElwee
(University of Texas, MD Anderson Cancer Center)
- Olatunji W. Williams
(Pediatrics, Peyton Manning Children’s Hospital)
- Elizabeth Sanchez
(University of Texas, MD Anderson Cancer Center)
- Michelle G. Roy
(University of Texas, MD Anderson Cancer Center)
- Kristen N. Kindrachuk
(Immunopathogenesis Section, Program in Barrier Immunity and Repair, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health)
- Thomas A. Wynn
(Immunopathogenesis Section, Program in Barrier Immunity and Repair, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health)
- Holger K. Eltzschig
(University of Colorado School of Medicine)
- Michael R. Blackburn
(The University of Texas—Houston Medical School)
- Michael J. Tuvim
(University of Texas, MD Anderson Cancer Center)
- William J. Janssen
(University of Colorado School of Medicine
National Jewish Health)
- David A. Schwartz
(University of Colorado School of Medicine)
- Burton F. Dickey
(University of Texas, MD Anderson Cancer Center)
Abstract
In asthma, airflow obstruction is thought to result primarily from inflammation-triggered airway smooth muscle (ASM) contraction. However, anti-inflammatory and smooth muscle-relaxing treatments are often temporary or ineffective. Overproduction of the mucin MUC5AC is an additional disease feature that, while strongly associated pathologically, is poorly understood functionally. Here we show that Muc5ac is a central effector of allergic inflammation that is required for airway hyperreactivity (AHR) to methacholine (MCh). In mice bred on two well-characterized strain backgrounds (C57BL/6 and BALB/c) and exposed to two separate allergic stimuli (ovalbumin and Aspergillus extract), genetic removal of Muc5ac abolishes AHR. Residual MCh responses are identical to unchallenged controls, and although inflammation remains intact, heterogeneous mucous occlusion decreases by 74%. Thus, whereas inflammatory effects on ASM alone are insufficient for AHR, Muc5ac-mediated plugging is an essential mechanism. Inhibiting MUC5AC may be effective for treating asthma and other lung diseases where it is also overproduced.
Suggested Citation
Christopher M. Evans & Dorota S. Raclawska & Fani Ttofali & Deborah R. Liptzin & Ashley A. Fletcher & Daniel N. Harper & Maggie A. McGing & Melissa M. McElwee & Olatunji W. Williams & Elizabeth Sanche, 2015.
"The polymeric mucin Muc5ac is required for allergic airway hyperreactivity,"
Nature Communications, Nature, vol. 6(1), pages 1-11, May.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7281
DOI: 10.1038/ncomms7281
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7281. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.